According to the research report titled ‘Drug of Abuse Testing Market Size By Product (Analyzers {Breath Analyzers Immunoassay Analyzers, Chromatographic Analyzers}), Rapid Testing Devices, Consumables), By Sample (Urine, Saliva, Hair), By End-use (Hospitals, Forensic Laboratories, Diagnostic Laboratories, Law Enforcement Agencies), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Japan, China, India, Australia, Brazil, Mexico, South Africa, GCC Countries), Application Potential, Competitive Market Share & Forecast, 2019 - 2025’, available with Market Study Report, global drug of abuse testing market is projected to surpass USD 4.8 billion by the end of the forecast period 2019-2025.
 

Escalating cases of drug abuse, favorable regulatory scenario in developed economies for testing substance abuse, and rising adopting of drug abuse testing devices among law enforcement agencies are supporting global drug of abuse testing market development. Growing number of clinical laboratories in developing economies is also adding considerable traction to the industry expansion.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2337489/
 

Technological advancements are further enhancing the industry growth. In fact, there currently exists multiple substance abuse apps on the market, such as reSET-O, Nomo and WeConnect, which enable individuals to maintain their health condition. Moreover, self-reporting assessment enhances overall patient wellbeing and identifies the extent of drug problems.
 

Despite the positive industry outlook, lack of trained laboratory professionals are negatively impacting the businesses, claims the study.
 

Based on product terrain, global drug of abuse testing industry from rapid testing devices segment held USD 1 billion valuation in 2018 and is projected to record strong gains in the upcoming years. Rapid testing devices enable on-site screening for saliva alcohol, urine specimen, and hair, and provide instant health results. Easy usability and reduced test & result time as compared to traditional devices are supporting their demand.
 

In terms of end-use scope, law enforcement agencies segment accounted for over USD 700 million in 2018 and is projected to grow considerably over the forecast duration. Growing necessity for analyzers and rapid testing devices for routinized procedures in various departments along with high prevalence of drug testing practice in several private and public sector law organizations in the U.S. are supporting the segmental expansion.
 

As per geographical analysis, U.K. drug of abuse testing industry will exhibit 4.5% CAGR through 2025, attributable to high penetration of technologically advanced devices in the country. Moreover, high laboratory standards and stringent guidelines for drug testing in line with government efforts towards improving public health are contributing to the industry growth.
 

United States Drug Testing Laboratories Inc., Thermo Fisher Scientific Inc., Siemens Healthcare Pvt. Ltd., Randox Testing Services, Quest Diagnostics Inc., Laboratory Corporation of America Holdings, F. Hoffmann-La Roche Ltd., Drägerwerk AG & Co. KGaA, Danaher (Beckman Coulter Inc.), and Abbott Laboratories (Alere) are the major industry players.